Your browser doesn't support javascript.
loading
Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs).
Joannes, Audrey; Voisin, Tom; Morzadec, Claudie; Letellier, Alice; Gutierrez, Francisco Llamas; Chiforeanu, Dan Cristian; Le Naoures, Cécile; Guillot, Stéphanie; De Latour, Bertrand Richard; Rouze, Simon; Jaillet, Madeleine; Crestani, Bruno; Wollin, Lutz; Jouneau, Stéphane; Vernhet, Laurent.
Affiliation
  • Joannes A; Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000, Rennes, France. Electronic address: audrey.joannes@univ-rennes.fr.
  • Voisin T; Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000, Rennes, France.
  • Morzadec C; Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000, Rennes, France.
  • Letellier A; Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000, Rennes, France.
  • Gutierrez FL; Department of Pathology and Cytology, Rennes University Hospital, 35033, Rennes, France.
  • Chiforeanu DC; Department of Pathology and Cytology, Rennes University Hospital, 35033, Rennes, France.
  • Le Naoures C; Department of Pathology and Cytology, Rennes University Hospital, 35033, Rennes, France.
  • Guillot S; Department of Respiratory Physiology, Rennes University Hospital, 35033, Rennes, France.
  • De Latour BR; Department of Thoracic, Cardiac and Vascular Surgery, Rennes University Hospital, 35033, Rennes, France.
  • Rouze S; Department of Thoracic, Cardiac and Vascular Surgery, Rennes University Hospital, 35033, Rennes, France.
  • Jaillet M; Faculté de Médecine Xavier Bichat, Université de Paris, Institut National de la Santé et de la Recherche Médicale (INSERM), UMR1152, FHU APOLLO, Labex INFLAMEX, Paris, France.
  • Crestani B; Faculté de Médecine Xavier Bichat, Université de Paris, Institut National de la Santé et de la Recherche Médicale (INSERM), UMR1152, FHU APOLLO, Labex INFLAMEX, Paris, France; Department of Pulmonology, AP-HP, Hôpital Bichat, FHU APOLLO, Inserm 1152, University of Paris, Paris, France.
  • Wollin L; Boehringer Ingelheim Pharma GmbH & Co, KG, Biberach an der Riss, Germany.
  • Jouneau S; Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000, Rennes, France; Department of Respiratory Diseases, Competence Center for Rare Pulmonary Disease, Rennes University Hospital, 35033, Rennes, France.
  • Vernhet L; Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000, Rennes, France.
Pulm Pharmacol Ther ; 83: 102267, 2023 Dec.
Article in En | MEDLINE | ID: mdl-37972706
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoidosis / Lung Diseases, Interstitial / Idiopathic Pulmonary Fibrosis Limits: Animals / Humans Language: En Journal: Pulm Pharmacol Ther Journal subject: FARMACOLOGIA Year: 2023 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoidosis / Lung Diseases, Interstitial / Idiopathic Pulmonary Fibrosis Limits: Animals / Humans Language: En Journal: Pulm Pharmacol Ther Journal subject: FARMACOLOGIA Year: 2023 Document type: Article Country of publication: United kingdom